Category: Biotech

Vial-Themed Drug Royalty Tombstone

Lucite deal tombstone commemorating two related royatly transactions. Both deals involve the diabetes drug TZIELD. (23AKL274)

2 Images
Lucite financial tombstone, incorporating drug vials on recesses on a plexi base, commemorating two drug royalty transactions involoving DRI Healthcare.

First Patient Dosed Clinical Trial Commemorative

Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the  drug is intended for the treatment of obstructive sleep apnea. (23AZH173)

2 Images
Side view of Lucite commemorative recognizing a clinical study of a sleep apnea therapy.

Oculis Diamond-Shaped Deal Toy

Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)

3 Images
Side view of crystal financial tombstone marking a follow-on offering by Oculis. Headquartered in Geneva, the biopharmaceutical firm specializes in eye care products and treatments. Back view of diamond-shaped deal tombstone recognizing a public offering by Oculis. The ophthalmic biopharmaceutical company addresses a number of conditions, including diabetic macular edema, dry eye disease, and glaucoma.

Drug Vial Embedment Celebrating FDA Approval

Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)

1 Image

Heart-Shaped Lucite Tombstone

Lucite tombstone recognizing a registered direct offering by BioCardia. The Sunnyvale, California-based company develops cellular and cell-derived therapeutics for cardiovascular and pulmonary conditions. (23AKL286)

1 Image

Cancer Cell Therapy Deal Tombstone

Lucite deal tombstone recognizing the merger of Adatptimmune and TCR2 Therapeutics. Both companies develop treatments that re-engineer immune cells to treat cancer. (23AKL209)

2 Images
Lucite deal tombstone marking the merger of biotech firms Adaptimmune and TCR2 Therapeutics.

Drug Screening-Themed Deal Tombstone

Crystal deal tombstone marking a follow-on offering by life sciences company Intelligent Bio Solutions The design incorporates the firm’s drug screening cartridge. (23AJH030)

1 Image

UK Pharma Private Placement Tombstone

Crystal financial tombstone marking a private placement by Midatech Pharma. The drug delivery technology firm is based in the UK. (23AJH028)

1 Image

Data Analytics Funding Round Tombstone

Crystal financial tombstone celebrating Series A funding for Lokavant. Based in New York, Lokavant provides a centralized data repository for clinical drug trials. (23AKL083)

3 Images
Side view of faceted crystal commemorative marking a funding round for Lokavant.
DAVID TAYLOR DIGITAL | DIGITAL MARKETING AGENCY